The dental membrane and bone graft substitute market in the US is growing at a CAGR of 11.4% from 2023 to 2028.
Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) — Dental membranes are barrier membranes used for two processes: guided tissue regeneration (GTR) and guided bone regeneration (GBR). The functions of membranes are to provide biosafety, biocompatibility and appropriate mechanical properties. Also, a dental membrane must be bioactive to promote tissue regeneration. Various commercially available membranes are on the market and continuous research and development of new membranes is being carried out to introduce new ones. For dental procedures, bone grafts are used for facial trauma treatment, tooth extractions, placement of dental implants, and reconstructive surgery of the mouth, face, and jaw. Bone graft substitutes are natural or synthetic materials that often contain only mineralized bone matrix without viable cells.
According to our new research study on “Buy dental veneers and bone grafts in the US Forecast to 2028 – Country Analysis by Type (Dental Bone Graft Substitutes, Dental Barrier Membrane, Grafting Procedure and Dental Soft Tissue Regeneration), Process (Dental Barrier Membrane and Graft Procedures) and End User (Hospitals, Dentistry and Other Clinics)’, the US dental membrane and bone graft substitute market share will reach $12.76 billion by 2028 from $6.82 billion in 2022. The market is estimated to grow at a CAGR of 11.4% from 2023 to in 2028.
Download Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00029894
US Dental Veneers and Bone Graft Substitutes Market: Competitive Landscape and Key Developments
Dentsply Sirona Inc, Dentium Co Ltd, Geistlich Pharma AG, ZimVie Inc, Keystone Dental Inc, Straumann Holding AG, Medtronic Plc, BioHorizons Inc, MEDOSIS and LifeNet Health Inc. is among the leading companies operating in the US global dental membrane and bone substitute market. These players are focusing on expanding and diversifying their market presence and acquiring a new customer base, thus capitalizing on the dominant business opportunities in the US Dental Films and Bone Graft Substitutes market. Many market players are launching their innovative products in the US dental membrane and bone graft substitute market with advanced features. For example,
In April 2023, ZimVie Inc. announced the launch of two products, RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug. The launch of these products has expanded ZimVie, Inc.’s portfolio of biomaterials. intended for filling extraction sockets and periodontal defects. The products are marketed in North America.
In March 2023, ZimVie Inc. announced the release of its publication “Comparison of the effects of tissue processing on the physicochemical properties of bone allografts”. The article was published in The International Journal of Oral & Maxillofacial Implants. The article showed the impact of different tissue processing methods of its products, such as the bone substitute Puros Cancellous Particulate Allograft, Creos, OraGraft and MinerOss.
In June 2022, BioHorizon signed an exclusive patent and trademark license agreement and an exclusive distribution and supply agreement with Orthocell Limited. As part of the agreement, Orthocell granted BioHorizons its exclusive license to two patent families covering a collagen scaffold for cell growth and a method of producing a collagen membrane, related patent applications, improvements and know-how, and the trademark Striate+.
In October 2022, Geistlich Pharma announced the acquisition of Lynch Biologics, LLC. The acquisition helped Geistlich Pharma strengthen its portfolio by adding Lynch Biologics, LLC’s flagship product GEM 21S, which is based on a growth factor that accelerates bone formation and wound healing. The companies aim to promote new regenerative technologies in dentistry.
In October 2022, LifeNet Health presented its advanced biologic allografts for fusion at the North American Spine Society (NASS) 2022 Annual Meeting in October 2022.
Technological Advancements in Dentistry to Offer Opportunities for the US Dental Veneers and Bone Graft Substitutes Market During 2023 to 2028:
Technological advances make it easier for dentists to do their work quickly, safely and comfortably. Technologically advanced instruments make dental hygiene appointments much more enjoyable for patients than they used to be. As a result, patients become compliant and willingly schedule treatment and cancel visits. Restorative dentistry benefits overall oral health, especially facial appearance, along with effective dental care and oral care. Using new dental implant techniques and advanced navigation and tracking technologies, dentists can insert implants through minimally invasive surgical procedures. Augmented reality (AR) technology is more prevalent in restorative and cosmetic dentistry, as artificial intelligence can show patients how they would care for the treatment. Also, increasing adoption of synthetic bone substitutes is likely to favor the growth of the dental veneers and bone grafts market in the US. For example, in 2020, Orthopediatrics Corp., a company focused exclusively on pediatric orthopedics, launched QuickPack, a fully synthetic replacement containing a high-viscosity calcium phosphate cement that mimics the mineral phase of natural bone. In July 2020, Spine Wave Inc. announced the successful launch of its trial allograft bone matrix. The Tempest allograft bone matrix comprises cancellous and partially deionized cortical bone. Such technological advancements in dental membrane and bone grafts are expected to provide growth opportunities in the US market in the coming years.
Order a copy of this report at https://www.theinsightpartners.com/buy/TIPRE00029894
US Dental Veneers and Bone Graft Substitutes Market: Sector-wise Overview
The US dental membrane and bone graft substitute market, by type, is segmented into dental bone graft substitutes, dental barrier membrane, grafting procedures, and dental soft tissue regeneration. The graft procedures segment is likely to hold the largest market share in 2022. However, the dental soft tissue regeneration segment is expected to register the highest CAGR in the market during the forecast period. Dental bone grafting is a surgical treatment that replaces and joins damaged or missing body tissues with synthetic, natural or artificial substitutes. These graft treatments can treat bone deformities caused by disease, trauma, or resorption. In dentistry, bone grafts are used as fillers. Grafting procedures are divided into connective tissue and free gingival grafts. Currently, free gingival grafting (FGG) is considered one of the standard approaches for soft tissue augmentation around dental implants. Free gingival grafting (FGG) remains a common root coverage procedure in areas of inadequate gingival attachment.
Read further research published by The Insight Partners:
Dental Market – Global analysis and forecast to 2028
Dental CAD/CAM market – Global analysis and forecast to 2027
About us:
Insight Partners is a provider of actionable industry research. We help our clients to find solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as semiconductors and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, chemicals and materials.
Contact us:
If you have any questions about this report or would like more information, please contact us:
Contact Person: Ankit Mathur
E-MAIL: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press release:
